A new study suggests a promising alternative to previous attempts to remove the sticky, toxic amyloid beta plaques from brains with Alzheimer’s Disease: enhancing the brain’s own immune cells to clear these plaques more effectively. The findings could …
Two new studies led by researchers at Hospital for Special Surgery (HSS) have uncovered key biological mechanisms driving systemic sclerosis (SSc), or scleroderma—a rare and often devastating autoimmune disease that causes fibrosis (tissue hardening) a…
For more than three decades, scientists have been racing to stop Alzheimer’s disease by removing amyloid beta plaques—sticky clumps of toxic protein that accumulate in the brain.
The U.S. Food and Drug Administration has expanded its indication of ALK’s Odactra, a house dust mite allergen tablet, for the treatment of house dust mite-induced allergic rhinitis, with or without conjunctivitis, to include children ages 5 through 11…
The body’s internal clock doesn’t just dictate when we sleep — it also determines how quickly our muscles heal. A new study in mice suggests that muscle injuries heal faster when they occur during the body’s natural waking hours.
The body’s internal clock doesn’t just dictate when we sleep—it also determines how quickly our muscles heal. A new Northwestern Medicine study in mice, published today in Science Advances, suggests that muscle injuries heal faster when they occur duri…
The virus that causes COVID-19 has been very good at mutating to keep infecting people—so good that most antibody treatments developed during the pandemic are no longer effective. Now a team led by Stanford University researchers may have found a way t…
Researchers have found that women who exhibit disturbed eating behaviors and engage in low physical activity tend to have more central body fat and a higher risk of metabolic low-grade inflammation. This condition increases the risk of cardiovascular d…
A live-attenuated tuberculosis (TB) vaccine candidate in development elicits a much more balanced and effective immune response compared to the existing vaccine used across much of the world, according to preclinical research.
People with Crohn’s disease and related joint inflammation linked to immune system dysfunction have distinct gut bacteria or microbiota, with the bacterium Mediterraneibacter gnavus being a potential biomarker, according to new study.
